• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估三种用于检测淋巴结转移的信使核糖核酸标志物。

Evaluation of three mRNA markers for the detection of lymph node metastases.

作者信息

Berger Jennifer, Mueller-Holzner Elisabeth, Fiegl Heidi, Marth Christian, Daxenbichler Guenter

机构信息

Department of Obstetrics and Gynecology, Innsbruck University Hospital, Innsbruck, Austria.

出版信息

Anticancer Res. 2006 Sep-Oct;26(5B):3855-60.

PMID:17094413
Abstract

The expressions of three mRNA markers were correlated with the results of extensive histopathological examination of a total of 290 axillary lymph nodes from 29 breast carcinoma patients. Included were two established markers for breast cancer (cytokeratin-19 and mammaglobin) and the novel marker DNA methyltransferase 3b (DNMT3b). DNMT3b was significantly overexpressed in breast cancer compared to normal breast tissue. The expression of the three markers in axillary lymph nodes was determined using quantitative real-time RT-PCR. DNMT3b expression showed a specificity of more than 99%, which was comparable to that of cytokeratin-19 and better than that of mammaglobin. The sensitivity of RT-PCR relative to histopathology was highest for cytokeratin-19 (96%), followed by DNMT3b (88%) and mammaglobin (68%). The overall agreement of histological and RT-PCR results was 96-99%. The results indicate that expression analysis of marker genes by quantitative RT-PCR can be a useful tool for lymph node diagnosis in breast cancer.

摘要

对29例乳腺癌患者共290个腋窝淋巴结进行广泛组织病理学检查,结果显示三种mRNA标志物的表达与之相关。其中包括两种已确立的乳腺癌标志物(细胞角蛋白-19和乳腺珠蛋白)以及新型标志物DNA甲基转移酶3b(DNMT3b)。与正常乳腺组织相比,DNMT3b在乳腺癌中显著过表达。采用定量实时逆转录聚合酶链反应(RT-PCR)测定腋窝淋巴结中这三种标志物的表达。DNMT3b表达的特异性超过99%,与细胞角蛋白-19相当,优于乳腺珠蛋白。RT-PCR相对于组织病理学的敏感性,细胞角蛋白-19最高(96%),其次是DNMT3b(88%)和乳腺珠蛋白(68%)。组织学和RT-PCR结果的总体一致性为96%-99%。结果表明,通过定量RT-PCR分析标志物基因的表达可作为乳腺癌淋巴结诊断的有用工具。

相似文献

1
Evaluation of three mRNA markers for the detection of lymph node metastases.评估三种用于检测淋巴结转移的信使核糖核酸标志物。
Anticancer Res. 2006 Sep-Oct;26(5B):3855-60.
2
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.乳腺癌淋巴结转移的mRNA标志物:248例患者中乳腺珠蛋白与癌胚抗原的比较
J Pathol. 2001 Sep;195(2):186-90. doi: 10.1002/path.943.
3
Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.通过逆转录聚合酶链反应检测腋窝淋巴结中的乳腺癌微转移。MUC1 mRNA与角蛋白19 mRNA扩增的比较。
Am J Pathol. 1996 Feb;148(2):649-56.
4
Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients.对乳腺癌患者腋窝前哨淋巴结进行乳腺珠蛋白和细胞角蛋白19的广泛组织病理学检查与实时逆转录-聚合酶链反应检测的比较评估。
Ann Surg. 2008 Jan;247(1):136-42. doi: 10.1097/SLA.0b013e318157d22b.
5
Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.乳腺癌患者前哨淋巴结分子转移与圣加仑风险分类之间的相关性。
Eur J Surg Oncol. 2007 Feb;33(1):16-22. doi: 10.1016/j.ejso.2006.09.013. Epub 2006 Oct 27.
6
Mammaglobin, a potential marker of breast cancer nodal metastasis.乳腺珠蛋白,一种乳腺癌淋巴结转移的潜在标志物。
J Pathol. 1999 Sep;189(1):28-33. doi: 10.1002/(SICI)1096-9896(199909)189:1<28::AID-PATH389>3.0.CO;2-H.
7
Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA.通过实时定量逆转录聚合酶链反应检测乳腺珠蛋白1 mRNA评估乳腺癌患者腋窝前哨淋巴结状态。
Breast Cancer Res Treat. 2006 Jul;98(2):185-90. doi: 10.1007/s10549-005-9148-x. Epub 2006 Mar 15.
8
Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.胆管癌淋巴结微转移的基因检测
Clin Cancer Res. 2000 Jun;6(6):2326-32.
9
A validation study of a new molecular diagnostic assay: the Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes.一种新型分子诊断检测方法的验证研究:达特茅斯-希区柯克医学中心应用 GeneSearch BLN 检测方法检测乳腺前哨淋巴结的经验。
Exp Mol Pathol. 2010 Feb;88(1):1-6. doi: 10.1016/j.yexmp.2009.10.004. Epub 2009 Oct 17.
10
Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.用于检测乳腺癌患者前哨淋巴结微小残留病的多标志物逆转录聚合酶链反应检测法
Br J Cancer. 2006 Mar 13;94(5):681-5. doi: 10.1038/sj.bjc.6602992.

引用本文的文献

1
The Enigma of Mammaglobin: Redefining the Biomarker Paradigm in Breast Carcinoma.乳腺珠蛋白之谜:重新定义乳腺癌的生物标志物范式。
Int J Mol Sci. 2023 Aug 29;24(17):13407. doi: 10.3390/ijms241713407.
2
DNMT3A and DNMT3B in Breast Tumorigenesis and Potential Therapy.DNMT3A和DNMT3B在乳腺肿瘤发生及潜在治疗中的作用
Front Cell Dev Biol. 2022 May 10;10:916725. doi: 10.3389/fcell.2022.916725. eCollection 2022.
3
Detection of mammagloblin by RT-PCR as a biomarker for lymph node metastasis in breast cancer patients: A systematic review and meta-analysis.
通过 RT-PCR 检测乳球蛋白作为乳腺癌患者淋巴结转移的生物标志物:系统评价和荟萃分析。
PLoS One. 2019 May 23;14(5):e0216989. doi: 10.1371/journal.pone.0216989. eCollection 2019.
4
Human mammaglobin in breast cancer: a brief review of its clinical utility.人乳腺珠蛋白在乳腺癌中的应用:临床效用简述
Indian J Med Res. 2014 May;139(5):675-85.